CenterWatch

Clinical Trial Details

Overview

Research Study Summary

Juvenile Idiopathic Arthritis (JIA) - Minors

Purpose

Parents with children with Juvenile Idiopathic Arthritis (JIA) are asked to participate in a research study being conducted by Schneider Children's Hospital.

Patient Inclusion Criteria
Your child may be eligible to participate in this study if your child:

  • Is 4 to 17 years old
  • Has been diagnosed with JIA
  • Is taking Humira® or MTX therapy

Patient Exclusion Criteria
Your child may not participate in this study if your child:

  • Cannot be treated with Humira®
  • Has been treated with any approved or experimental drug such as etanercept (Enbrel®), abatacept (Orencia®), infliximab (Remicade®) or rituximab (Rituxan®).
  • Has participated in another research study within the last 30 days.

To Learn more

CW ID:140123
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
4 to 17 Years
Overall Status
Recruiting
Facility Type
N/A

Contact

Marilynn Orlando, Study Coordinator
Biomedical Research Alliance of New York
Schneider Children's Hospital
269-01 76th Avenue
New Hyde Park, NY 11040
Phone: 718-470-3530
Fax: 718-831-0182

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.